Home » Topics » Science » New compound

New compound
RSS

Tyrosine kinase inhibitor developed by Cephalon and TAP enters clinical trials

Oct. 18, 1996

New cPLA2 inhibitor from Merckle

Oct. 18, 1996

Retroviral zinc finger inhibitors as anti-HIV agents

Oct. 18, 1996

Novel, highly potent antihyperglycemic agents from SmithKline Beecham

Oct. 11, 1996

New antioxidant for atherosclerosis

Oct. 11, 1996

Novel free radical-scavenging and neuroprotective substance isolated by Japanese researchers

Oct. 11, 1996

New hypocholesterolemic agent from Schering-Plough

Oct. 11, 1996

New strategy for reducing doxorubicin toxicity

Oct. 11, 1996

Kanebo reports antitumor agent with a novel mechanism of action

Oct. 11, 1996

MMP inhibitors from Otsuka

Oct. 11, 1996

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...